| Year |
Citation |
Score |
| 2010 |
Pang Y, Wang X, Ucuzian AA, Brey EM, Burgess WH, Jones KJ, Alexander TD, Greisler HP. Local delivery of a collagen-binding FGF-1 chimera to smooth muscle cells in collagen scaffolds for vascular tissue engineering. Biomaterials. 31: 878-85. PMID 19853908 DOI: 10.1016/J.Biomaterials.2009.10.007 |
0.335 |
|
| 2008 |
Brewster LP, Washington C, Brey EM, Gassman A, Subramanian A, Calceterra J, Wolf W, Hall CL, Velander WH, Burgess WH, Greisler HP. Construction and characterization of a thrombin-resistant designer FGF-based collagen binding domain angiogen. Biomaterials. 29: 327-36. PMID 17950455 DOI: 10.1016/J.Biomaterials.2007.09.034 |
0.375 |
|
| 2006 |
Grieb TA, Forng RY, Bogdansky S, Ronholdt C, Parks B, Drohan WN, Burgess WH, Lin J. High-dose gamma irradiation for soft tissue allografts: High margin of safety with biomechanical integrity. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 24: 1011-8. PMID 16514624 DOI: 10.1002/Jor.20079 |
0.701 |
|
| 2005 |
Grieb TA, Forng RY, Stafford RE, Lin J, Almeida J, Bogdansky S, Ronholdt C, Drohan WN, Burgess WH. Effective use of optimized, high-dose (50 kGy) gamma irradiation for pathogen inactivation of human bone allografts. Biomaterials. 26: 2033-42. PMID 15576177 DOI: 10.1016/J.Biomaterials.2004.06.028 |
0.7 |
|
| 2004 |
Brewster LP, Brey EM, Tassiopoulos AK, Xue L, Maddox E, Armistead D, Burgess WH, Greisler HP. Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM). American Journal of Surgery. 188: 575-9. PMID 15546573 DOI: 10.1016/J.Amjsurg.2004.07.012 |
0.348 |
|
| 2004 |
Tran H, Marlowe K, McKenney K, Petrosian G, Griko Y, Burgess WH, Drohan WN, Imboden MA, Kempf C, Boschetti N, Mann DM. Functional integrity of intravenous immunoglobulin following irradiation with a virucidal dose of gamma radiation. Biologicals : Journal of the International Association of Biological Standardization. 32: 94-104. PMID 15454188 DOI: 10.1016/J.Biologicals.2004.01.002 |
0.375 |
|
| 2003 |
Amareld RW, Wersocki M, Drohan M, Drohan WN, Burgess WH, Mann DM, Forng RY. Controlled gamma-irradiation mediated pathogen inactivation of human urokinase preparations with significant recovery of enzymatic activity. Biologicals : Journal of the International Association of Biological Standardization. 31: 261-4. PMID 14624796 DOI: 10.1016/J.Biologicals.2003.07.001 |
0.42 |
|
| 2003 |
Erzurum VZ, Bian JF, Husak VA, Ellinger J, Xue L, Burgess WH, Greisler HP. R136K fibroblast growth factor-1 mutant induces heparin-independent migration of endothelial cells through fibrin glue. Journal of Vascular Surgery. 37: 1075-81. PMID 12756357 DOI: 10.1067/Mva.2003.177 |
0.366 |
|
| 2003 |
Burgess W, Grieb T, Lin J, Forng R, Almeida J, Parks B, Drohan W. P66. A novel process for sterilizing allografts using 50 kGy of gamma irradiation The Spine Journal. 3: 128-129. DOI: 10.1016/S1529-9430(03)00310-3 |
0.689 |
|
| 2002 |
Grieb T, Forng RY, Brown R, Owolabi T, Maddox E, McBain A, Drohan WN, Mann DM, Burgess WH. Effective use of gamma irradiation for pathogen inactivation of monoclonal antibody preparations. Biologicals : Journal of the International Association of Biological Standardization. 30: 207-16. PMID 12217345 DOI: 10.1006/Biol.2002.0330 |
0.693 |
|
| 2001 |
Xue L, Tassiopoulos AK, Woloson SK, Stanton DL, Ms CS, Hampton B, Burgess WH, Greisler HP. Construction and biological characterization of an HB-GAM/FGF-1 chimera for vascular tissue engineering. Journal of Vascular Surgery. 33: 554-60. PMID 11241127 DOI: 10.1067/Mva.2001.112229 |
0.373 |
|
| 2000 |
Maddox E, Zhan M, Mundy GR, Drohan WN, Burgess WH. Optimizing human demineralized bone matrix for clinical application. Tissue Engineering. 6: 441-8. PMID 10992439 DOI: 10.1089/107632700418146 |
0.301 |
|
| 2000 |
Xue L, Shireman PK, Hampton B, Burgess WH, Greisler HP. The cysteine-free fibroblast growth factor 1 mutant induces heparin- independent proliferation of endothelial cells and smooth muscle cells Journal of Surgical Research. 92: 255-260. PMID 10896831 DOI: 10.1006/Jsre.2000.5945 |
0.374 |
|
| 2000 |
Grieb TA, Burgess WH. The mitogenic activity of fibroblast growth factor-1 correlates with its internalization and limited proteolytic processing. Journal of Cellular Physiology. 184: 171-82. PMID 10867641 DOI: 10.1002/1097-4652(200008)184:2<171::Aid-Jcp4>3.0.Co;2-J |
0.694 |
|
| 2000 |
Shireman PK, Xue L, Maddox E, Burgess WH, Greisler HP. The S130K fibroblast growth factor-1 mutant induces heparin-independent proliferation and is resistant to thrombin degradation in fibrin glue Journal of Vascular Surgery. 31: 382-390. PMID 10664506 DOI: 10.1016/S0741-5214(00)90168-X |
0.364 |
|
| 1999 |
Fedi P, Bafico A, Nieto Soria A, Burgess WH, Miki T, Bottaro DP, Kraus MH, Aaronson SA. Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling. The Journal of Biological Chemistry. 274: 19465-72. PMID 10383463 DOI: 10.1074/Jbc.274.27.19465 |
0.334 |
|
| 1999 |
LaRochelle WJ, Sakaguchi K, Atabey N, Cheon HG, Takagi Y, Kinaia T, Day RM, Miki T, Burgess WH, Bottaro DP. Heparan sulfate proteoglycan modulates keratinocyte growth factor signaling through interaction with both ligand and receptor. Biochemistry. 38: 1765-71. PMID 10026256 DOI: 10.1021/Bi982092Z |
0.337 |
|
| 1998 |
Grieb TW, Ring M, Brown E, Palmer C, Belle N, Donjerkovic D, Chang H, Yun J, Subramanian R, Forozan F, Guo Y, Vertes A, Winkles JA, Burgess WH. Primary structure of ovine fibroblast growth factor-1 deduced by protein and cDNA analysis. Biochemical and Biophysical Research Communications. 246: 182-91. PMID 9600090 DOI: 10.1006/Bbrc.1998.8597 |
0.33 |
|
| 1997 |
Donohue PJ, Hsu DK, Guo Y, Burgess WH, Winkles JA. Fibroblast growth factor-1 induction of delayed-early mRNA expression in NIH 3T3 cells is prolonged by heparin addition. Experimental Cell Research. 234: 139-46. PMID 9223379 DOI: 10.1006/Excr.1997.3598 |
0.339 |
|
| 1997 |
Nepomuceno RR, Henschen-Edman AH, Burgess WH, Tenner AJ. cDNA cloning and primary structure analysis of C1qR(p), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro Immunity. 6: 119-129. PMID 9047234 DOI: 10.1016/S1074-7613(00)80419-7 |
0.31 |
|
| 1995 |
Wong P, Hampton B, Szylobryt E, Gallagher AM, Jaye M, Burgess WH. Analysis of putative heparin-binding domains of fibroblast growth factor- 1. Using site-directed mutagenesis and peptide analogues Journal of Biological Chemistry. 270: 25805-25811. PMID 7592764 DOI: 10.1074/Jbc.270.43.25805 |
0.308 |
|
| 1995 |
Burgess WH, Friesel R, Winkles JA. Structure-function studies of FGF-1: dissociation and partial reconstitution of certain of its biological activities. Molecular Reproduction and Development. 39: 56-60; discussion 60. PMID 7528028 DOI: 10.1002/Mrd.1080390110 |
0.34 |
|
| 1994 |
Cheon HG, LaRochelle WJ, Bottaro DP, Burgess WH, Aaronson SA. High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains. Proceedings of the National Academy of Sciences of the United States of America. 91: 989-93. PMID 8302878 DOI: 10.1073/Pnas.91.3.989 |
0.324 |
|
| 1994 |
Gray JL, Kang SS, Zenni GC, Kim DU, Kim PI, Burgess WH, Drohan W, Winkles JA, Haudenschild CC, Greisler HP. FGF-1 Affixation Stimulates ePTFE Endothelialization without Intimal Hyperplasia Journal of Surgical Research. 57: 596-612. PMID 7526046 DOI: 10.1006/Jsre.1994.1189 |
0.317 |
|
| 1992 |
Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, Chan AM, Aaronson SA. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proceedings of the National Academy of Sciences of the United States of America. 89: 246-50. PMID 1309608 DOI: 10.1073/Pnas.89.1.246 |
0.329 |
|
| 1992 |
Egerton M, Ashe O, Chen D, Druker B, Burgess W, Samelson L. VCP, the mammalian homolog of cdc48, is tyrosine phosphorylated in response to T cell antigen receptor activation. The Embo Journal. 11: 3533-3540. DOI: 10.1002/J.1460-2075.1992.Tb05436.X |
0.309 |
|
| 1991 |
Rubin JS, Chan AM, Bottaro DP, Burgess WH, Taylor WG, Cech AC, Hirschfield DW, Wong J, Miki T, Finch PW. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proceedings of the National Academy of Sciences of the United States of America. 88: 415-9. PMID 1824873 DOI: 10.1073/Pnas.88.2.415 |
0.359 |
|
| 1990 |
Tharakan J, Strickland D, Burgess W, Drohan WN, Clark DB. Development of an immunoaffinity process for factor IX purification. Vox Sanguinis. 58: 21-29. PMID 2316207 DOI: 10.1111/J.1423-0410.1990.Tb02050.X |
0.305 |
|
| 1990 |
Burgess WH, Dionne CA, Kaplow J, Mudd R, Friesel R, Zilberstein A, Schlessinger J, Jaye M. Characterization and cDNA cloning of phospholipase C-gamma, a major substrate for heparin-binding growth factor 1 (acidic fibroblast growth factor)-activated tyrosine kinase. Molecular and Cellular Biology. 10: 4770-7. PMID 2167438 DOI: 10.1128/Mcb.10.9.4770 |
0.371 |
|
| 1990 |
Dionne CA, Crumley G, Bellot F, Kaplow JM, Searfoss G, Ruta M, Burgess WH, Jaye M, Schlessinger J. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. The Embo Journal. 9: 2685-2692. DOI: 10.1002/J.1460-2075.1990.Tb07454.X |
0.357 |
|
| 1989 |
Ruta M, Burgess W, Givol D, Epstein J, Neiger N, Kaplow J, Crumley G, Dionne C, Jaye M, Schlessinger J. Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG). Proceedings of the National Academy of Sciences of the United States of America. 86: 8722-6. PMID 2554327 DOI: 10.1073/Pnas.86.22.8722 |
0.306 |
|
| 1989 |
Friesel R, Burgess WH, Maciag T. Heparin-binding growth factor 1 stimulates tyrosine phosphorylation in NIH 3T3 cells. Molecular and Cellular Biology. 9: 1857-65. PMID 2473389 DOI: 10.1128/Mcb.9.5.1857 |
0.319 |
|
| 1987 |
Winkles JA, Friesel R, Burgess WH, Howk R, Mehlman T, Weinstein R, Maciag T. Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Proceedings of the National Academy of Sciences of the United States of America. 84: 7124-8. PMID 2444975 DOI: 10.1073/Pnas.84.20.7124 |
0.302 |
|
| Show low-probability matches. |